Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated chemotherapy and health-promotion intervention for soil-transmitted helminth and Opisthorchis viverrini infection in the Lower Mekong Basin
ACTRN12622000353796Phase 4Completed
- Sponsor
- Professor Darren Gray
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, open-label trial of praziquantel, albendazole and pyrantel in Soil-Transmitted Helminthiases (STH) and opisthorchiasis (2 arms), sponsored by Professor Darren Gray. Primary endpoints: OV infection rate, STH infection rate and 1 more. Started May 2023; status: completed.
02
Drugs
praziquantelalbendazolepyrantel
03
Conditions
Soil-Transmitted Helminthiases (STH)opisthorchiasis
Beyond the preview
Go deeper on ACTRN12622000353796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000353796.